Bladder cancer, a review of the environmental risk factors

Environmental Health: A Global Access Science Source

Volumn 11, Issue SUPPL.1, 2012, Pages

  Letaiová, Silvia ^a   Medveová, Albeta ^a   Ovíková, Andrea ^a   Duinská, Mária ^b,d   Volkovová, Katarína ^b   Mosoiu, Claudia ^c   Bartonová, Alena ^d  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^c Institute for Food Research Bucharest   (Romania)

^d NORWEGIAN INSTITUTE FOR AIR RESEARCH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

2 NAPHTHYLAMINE; 4 4 METHYLENEBIS(2 CHLOROANILINE); ARSENIC; BENZIDINE; DRINKING WATER; NICOTINE; TAR; UNCLASSIFIED DRUG;

ARSENIC; CANCER; DRINKING WATER; ENVIRONMENTAL RISK; EPIDEMIOLOGY; LITERATURE REVIEW; OCCUPATIONAL EXPOSURE; POLLUTION EXPOSURE; RISK FACTOR; SMOKING; SPATIOTEMPORAL ANALYSIS;

BANGLADESH; BLADDER CANCER; CANCER MORTALITY; CANCER PREVENTION; CANCER RECURRENCE; CANCER RISK; CHINA; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CYTOTOXICITY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENOTOXICITY; HIGH RISK POPULATION; HUMAN; HUNGARY; INDIA; NETHERLANDS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; RUBBER INDUSTRY; SEX DIFFERENCE; SMOKELESS TOBACCO; SMOKING CESSATION; STANDARDIZED MORTALITY RATIO; SYSTEMATIC REVIEW;

NICOTIANA TABACUM; SCOPUS;

EID: 84863312065     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-11-S1-S11     Document Type: Review

References (43)

1. Arsenic in drinking water and bladder cancer: review of epidemiological evidence. Meliker JR, Nriagu JO, Trace Metals and other Contaminants in the Environment 2007 9 551 584 (Pubitemid 351734469)
2. Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Larsson SC, Andersson SO, Johansson JE, Wolk A, Eur J Cancer 2008 44 17 2655 2660
3. Tobacco use and cancer causation: association by tumour type. Kuper H, Boffetta P, Adami HO, J Internal Medicine 2002 252 206 224
4. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. Zeegers MPA, Kellen E, Buntinx F, van den Brandt PA, World J Urol 2004 21 392 401
5. Bladder Cancer in Elderly. Shariat SF, Milowsky M, Droller MJ, Urol Oncopl 2009 27 653 667
6. Environmental factors and genetic susceptibility promote urinary bladder cancer. Volanis D, Kadiyska T, Galanis A, Delakas D, Logotheti S, Zoumpourlis V, Toxicology Letters 2010 193 131 137
7. Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guérin immunotherapy in bladder cancer. Ahirwar D, Kesarwani P, Manchanda PK, Mandhani A, Mittal RD, Cancer Genet Cytogenet 2008 184 1 8 (Pubitemid 351814965)
8. Malignant Non-Urothelial Neoplasms of the Urinary Bladder: A Review. Dahm P, Gschwend JE, Eur Urol 2003 44 672 681 (Pubitemid 37542925)
9. Mortality in relation to smoking. 40 years'observations on male British doctors. Doll R, Peto R, Wheatley K, Gray R, Sutherland I, Br Med J 1994 309 901 911
10. Clustering of concordant and discordant cancer types in Swedish couples is rare. Weires M, Bermejo JL, Sundquist J, Hemminki K, Eur J Cancer
11. Surveillance for cancers associated with tobacco use - United States, 1999-2004. Stewart SL, Cardinez CJ, Richardson LC, Norman L, Kaufmann R, Pechacek TF, Thompson TD, Weir HK, Sabatino SA, MMWR Surveill. Summ 2008 57 1 33
12. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiological studies. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA, Cancer 2000 89 630 639 (Pubitemid 30640110)
13. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Brennan P, Bogillot O, Cordier S, Greise E, Schill W, Vineis P, Lopez-Abente G, Tzonou A, Chang-Claude J, Bolm-Audorff U, Jöckel KH, Donato F, Serra C, Wahrendorf J, Hours M, T'Mannetje A, Kogevinas M, Boffeta P, Int J Cancer 2000 86 289 94 (Pubitemid 30180827)
14. The contribution of cigarette smoking to bladder cancer risk in women (pooled European data). Brennan P, Bogillot O, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S, Jöckel KH, Lopez-Abente G, Tzonou A, Vineis P, Donato F, Hours M, Serra C, Bolm-Audorff U, Schill W, Kogevinas M, Boffeta P, Cancer Causes Control 2001 12 411 417 (Pubitemid 32735134)
15. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Zeegers MP, Goldbohm RA, van den Brandt PA, Cancer Causes Control 2002 13 83 90 (Pubitemid 34163954)
16. Cigar, pipe, and cigarette smoking and bladder cancer risk in European men. Pitard A, Brennan P, Clavel J, Greiser E, Lopez-Abente G, Chang-Claude J, Wahrendorf J, Serra C, Kogevinas M, Boffeta P, Cancer Causes Control 2001 12 551 556 (Pubitemid 32735127)
17. Cigar smoking in men and risk of death from tobacco-related cancer. Shapiro JA, Jacobs EJ, Thun MJ, J Natl Cancer Inst 2000 92 333 337 (Pubitemid 30117737)
18. Tobacco smoking, occupational exposure and bladder cancer in Argentina. Iscovich J, Castelletto R, Esteve J, Munoz N, Colanzi R, Coronel A, Deamezola I, Tassi V, Arslan A, Int J Cancer 1987 40 734 740 (Pubitemid 18003868)
19. Environmental tobacco smoke and cancer of sites other than the lung in adult non- smokers. Lee PN, Food Chem Toxicol 2002 40 747 766 (Pubitemid 34450772)
20. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 89, Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines. 2007 227
21. Bladder cancer in nonsmokers. Kabat GC, Dieck GS, Wynder EL, Cancer 1986 57 362 367 (Pubitemid 16212044)
22. Passive smoking and cancer: an epidemiological review. Hirayama T, GANN Monograph on Cancer Research 1987 33 127 135
23. Risk of bladder cancer by source and type of exposure: a case control study. Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R, Miller AB, Int J Cancer 1989 44 622 628 (Pubitemid 19258734)
24. Smoking cessation after successful ttreatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, Ann Intern Med 1993 119 383 390 (Pubitemid 23310088)
25. Does smoking status influence the prognosis of bladder cancer? A systematic review. Aveyard P, Adab P, Cheng KK, Wallace DMA, Hey K, Murphy MFG, BJU Int 2002 90 228 239 (Pubitemid 34989068)
26. Ecotoxicology of arsenic in the hydrosphere: Implications for public health. Gbaruko BC, Ana GREE, Nwachukwu, African Journal of Biotechnology 2008 7 25 4737 4742
27. The biochemistry of environmental heavy metal uptake by plants: Implications for the food chain. Peralta-Videa JR, Lopez ML, Narayan M, Saupe G, Gardea-Torresdey, The International Journal of Biochemistry & Cell Biology 2009 41 1665 1677
28. Trace elements and cancer risk: a review of the epidemiologic evidence. Navarro Silvera SA, Rohan TE, Cancer Causes Control 2007 18 7 27 (Pubitemid 46020898)
29. Low-level arsenic exposure in drinking water and bladder cancer: A review. Mink PJ, Alexander DD, Barraj LM, Kelsch MA, Tsuji JS, Regulatory Toxicology and Pharmacology 2008 52 299 310
30. Arsenic in the aetiology of cancer. Review. Tapio S, Grosche B, Mutation Research 2006 612 215 146
31. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J, Environ Health Perspect 1999 107 705 710 (Pubitemid 29478879)
32. Arsenic exposure and its health effects and risk of cancer in developing countries: micronutrients as host defence. Anetor JI, Wanibuchi H, Fukushima S, Asian Pac J Cancer Prev 2007 8 13 23
33. P53 alterations in bladder tumors from arsenic and tobacco exposed patients. Moore LE, Smith AH, Eng C, DeVries S, Kalman V, Bhargava V, Chew K, Ferreccio C, Rey OA, Hopenhayn C, Biggs ML, Bates MN, Waldman FM, Carcinogenesis 2003 24 1785 1791 (Pubitemid 37408142)
34. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Andrew AS, Mason RA, Kelsey KT, Schned AR, Marsit CJ, Nelson HH, Karagas MR, Toxicology Letters 2009 187 10 14
35. Highlights of the Eight International Conference on Carcinogenic/ Mutagenic N-Substituted Aryl Compounds. Snyderwine EG, Sinha R, Felton J, Ferguson LR, Mutat Res 2002 506-507 1 8 (Pubitemid 35286535)
36. Arylamine exposures and bladder cancer risk. Yu MC, Skipper PL, Tannenbaum SR, Chan KK, Ross RK, Mutat Res 2002 506-507 21 28 (Pubitemid 35286536)
37. Bladder cancer screening and monitoring of 4,4'-methylenebis(2- chloroaniline) exposure among workers in Taiwan. Chen HI, Liou SH, Loh CH, Uang SN, Yu YC, Shih TS, Urology 2005 66 305 310
38. Mortality due to lung, laryngeal and bladder cancer in towns lying in the vicinity of combustion installations. Garcia-Pérez J, Pollán M, Boldo E, Pérez-Gámez B, Aragonés N, Lope V, Ramis R, Vidal E, Lápez-Abente G, Science of the Total Environment 2009 407 2593 2602
39. Tumours of the urinary bladder as an occupational disease in the rubber industry in England and Wales. Case RAM, Hosker ME, Br J Prev Soc Med 1954 8 39 50
40. Occupational exposure and urological cancer. Golka K, Wiese A, Assennato G, Bolt H, World J Urol 2004 21 382 391
41. 105Val) polymorphism in benzidine-exposed workers: an association with cytological grading of exfoliated urothelial cells. Ma QW, Lin GF, Qin YQ, Lu DR, Golka K, Geller F, Chen JG, Shen JH, Pharmacogenetics 2003 13 409 415 (Pubitemid 36900736)
42. Use of permanent hair dyes and bladder-cancer risk. Gago-Dominguez M, Castelao JE, Yuan JM, Yu MC, Ross RK, Int J Cancer 2001 91 575 579 (Pubitemid 32115116)
43. Most cancer in firefighters is due to radio-frequency radiation exposure not inhaled carcinogens. Milham S, Medical Hypotheses 2009 73 788 789